Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
MEK1/2 and Raf inhibitor.
Expectorant.
Antineoplastic immunomodulator.
Metal ion chelator, viral DNA polymerase inhibi...
Islet α/β cell proliferation stimulator.
5-HT2A antagonist, potential α1-adrenergic ant...
Diterpene found in Salvia.
Recombinant HIV glycoprotein antigen fragment.<...
Surfactant found in coconut oil.
Retinoid, differentiation inducer.
Alpha blocker and vasoactive agent.
ITC, sulforaphane analog.
Diterpene found in coffee beans.
Tropane alkaloid found in Solanaceae plants; α...
Anthracycline, DNA intercalator; topoisomerase ...
Impurity of diclofenac
STING inhibitor
ACE inhibitor.
SGLT2 inhibitor
Diaminoquinazoline derivative.